Search
Selected: C

Cytostatin II

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fusion protein or fusion polypeptide
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytostatin II antibodies and methods

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytostatin II antibodies and methods

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytostatin III

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytostatin III nucleic acids encoding

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytotactin derivatives that stimulate attachment and neurite...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytotoxic agent against specific virus infection

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytotoxic agent against specific virus infection

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytotoxic agent containment kit

Special receptacle or package – Combined or convertible – Packaged assemblage or kit
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytotoxic agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytotoxic agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytotoxic agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytotoxic agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytotoxic agents and methods of use

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytotoxic agents and methods of use

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytotoxic agents bearing a reactive polyethylene glycol...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytotoxic agents comprising maytansinoids and their therapeutic

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytotoxic agents comprising maytansinoids and their therapeutic

Drug – bio-affecting and body treating compositions – Lymphokine
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytotoxic agents comprising modified doxorubicins and...

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cytotoxic agents comprising new C-2 modified taxanes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.